Androgenetic alopecia is the most common form of hair loss, affecting up to 80% of men and 50% of women by age 70. It’s the gradual, patterned thinning you might know as male-pattern or female-pattern baldness. The process is driven by a combination of genetics and hormones, and it follows predictable patterns that differ between men and women.
How Hair Follicles Shrink Over Time
The core problem in androgenetic alopecia is something called follicular miniaturization. Hair follicles on your scalp slowly shrink, producing thinner, shorter, lighter hairs with each growth cycle until they eventually produce hairs so fine they’re nearly invisible. Large, healthy “terminal” hairs are gradually replaced by tiny “vellus” hairs, the kind of soft peach fuzz you see on a child’s forearm.
This shrinking is triggered by androgens, particularly a hormone called DHT (dihydrotestosterone). Your body converts testosterone into DHT using an enzyme, and DHT then binds to receptors in susceptible hair follicles. When it does, it shortens the active growth phase of the hair cycle and causes the follicle to produce progressively weaker hairs. Not all follicles on your head are equally vulnerable. The follicles along your hairline and crown are sensitive to DHT, while follicles on the sides and back of your head are largely resistant. That’s why balding follows a pattern rather than happening all at once.
Within a single cluster of follicles, miniaturization doesn’t hit every hair simultaneously. Secondary follicles shrink first, and the primary follicle is the last to go. This is why thinning areas often still have some normal-looking hairs mixed in with finer ones, especially early on. One important detail: as follicles miniaturize, they lose their attachment to the tiny muscle that makes your hair “stand on end.” Once that connection is severed, the miniaturization becomes irreversible, which is why early treatment matters.
Genetics and Risk Factors
The condition clusters in families, and having a close relative with patterned hair loss increases your risk. Researchers have confirmed that variations in the AR gene play a direct role. This gene controls how your body builds androgen receptors, the proteins that respond to DHT. People with certain AR gene variants have androgen receptors that are more easily activated by DHT than normal, which means their hair follicles are more sensitive to the hormone even at typical levels.
Beyond the AR gene, researchers suspect multiple other genes contribute, but none have been confirmed with the same certainty. The inheritance pattern is complex and doesn’t follow a simple “one parent passes it down” model. Environmental factors also play a role, which is why even identical twins can experience different degrees of hair loss.
How It Looks in Men vs. Women
Men and women lose hair in distinctly different patterns, and the timing differs too. In men, hair loss tends to start younger. About 23% of men in their twenties and 30% of men in their thirties show signs. In women, hair loss typically becomes noticeable later, with the highest rates appearing after menopause (around 29% of women in their sixties).
The Male Pattern
Male hair loss is classified using a seven-stage system. It begins with minor recession at the temples (the familiar “M-shaped” hairline), then progresses to deeper temple recession and thinning on the crown. Over time, the two thinning areas expand and merge, leaving only a horseshoe-shaped band of hair along the sides and back of the head in the most advanced stage. Not everyone progresses through all stages, and the rate varies widely from person to person.
The Female Pattern
Women rarely experience the receding hairline that men do. Instead, hair thins diffusely across the top of the scalp, starting about 1 to 3 centimeters behind the front hairline. The frontal hairline itself usually stays intact. This is graded on a three-level scale, from perceptible thinning on the crown (Grade I) to pronounced thinning (Grade II) to complete baldness in that area (Grade III). Most women stay in the earlier grades.
How It’s Diagnosed
A dermatologist can usually diagnose androgenetic alopecia based on the pattern of thinning alone, but a magnified scalp exam (dermoscopy) provides confirmation. The hallmark finding is hair shaft thickness variation on the top of the scalp: thick hairs mixed with progressively thinner ones in the same area. Additional signs include a high proportion of single-hair follicle clusters (30% or more), more than 10% vellus hairs in the affected area, and specific scalp markers like brown halos around hair shafts or yellow and white dots.
Importantly, certain findings rule out androgenetic alopecia and point to other conditions instead. Black dots, broken hairs, and “exclamation mark” hairs (short hairs that taper toward the scalp) suggest something else entirely, like an autoimmune form of hair loss. A scalp biopsy is rarely needed but may be performed if the pattern is unusual or the diagnosis is uncertain.
Treatment Options and What to Expect
Two main medications have decades of evidence behind them, and several newer approaches are gaining traction. The most important thing to know upfront is that all treatments require patience. Visible improvement takes 3 to 6 months, and full results typically require 9 to 12 months of consistent daily use.
Minoxidil
Minoxidil is a topical treatment applied directly to the scalp, available over the counter in 2% and 5% concentrations. It works by increasing blood flow to hair follicles and extending the active growth phase of the hair cycle. Most users begin to see results around four months of consistent use, with full effects visible between 6 and 12 months. The most common side effects in clinical trials were minor: headache (1.7% with the 5% formula), itching (about 1-2%), and occasional skin rash. If you stop using it, the hair loss resumes.
Finasteride
Finasteride works by blocking the enzyme that converts testosterone into DHT, reducing DHT levels and slowing follicle miniaturization. It’s FDA-approved for men only (1 mg daily, taken as a pill) and is not approved for use in women. Visible thickening usually appears between 3 and 6 months, with full results taking up to a year.
Side effects have been a point of concern and discussion. Early clinical trials of oral finasteride found that 3.8% of participants experienced sexual side effects like decreased libido or erectile dysfunction, and 1.4% stopped treatment because of them. However, a large real-world study of over 638,000 men using topical finasteride (applied to the scalp rather than taken orally) found much lower rates: sexual side effects were reported by just 0.002% of patients, and 80% of those who completed a follow-up reported being satisfied with treatment. Topical formulations deliver the drug more directly to the scalp and may reduce systemic exposure.
Platelet-Rich Plasma (PRP)
PRP therapy involves drawing a small amount of your blood, concentrating the growth-factor-rich platelets, and injecting them into the scalp. These growth factors appear to prolong the active growth phase of hair and support the cells at the base of the follicle. In clinical studies, 57% of patients reported new hair growth and 64% noticed improvement in hair density based on their own assessment. A network analysis comparing multiple treatments ranked PRP as the most effective option for male androgenetic alopecia.
Low-Level Laser Therapy
Low-level laser therapy uses red light devices (caps, combs, or helmets) to stimulate stem cells in the hair follicle and push resting follicles back into their active growth phase. A network analysis of treatments for female androgenetic alopecia ranked laser therapy as the most effective of the options studied. It’s non-invasive and has minimal side effects, though it requires regular, ongoing use.
Combining Treatments
Many people use minoxidil and finasteride together, sometimes adding PRP or laser therapy. Even with combined treatment, the timeline remains similar: 3 to 6 months for initial improvement, 9 to 12 months for full benefit. Because androgenetic alopecia is progressive and miniaturization can become irreversible, earlier treatment generally preserves more hair than starting after significant loss has already occurred.